Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02299193 · ClinicalTrials.gov registry record · NA
Online CBT-I for High Blood Pressure
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT02299193: Completed NA study, sponsored by Emory University.
NCT02299193 is a NA study that has completed, run by Emory University. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02299193, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effect of 6-weekly, 20 minute sessions of 2 online behavioral sleep interventions (cognitive behavioral therapy or healthy sleep habits) on blood pressure, sleep, depressive symptoms and anxiety in people with insomnia and prehypertension or hypertension.
Primary Outcome
Systolic blood pressure will be measured at baseline, 8 and 20 weeks
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Healthy Sleep Habits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2014-08 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02299193 record still lists
NCT02299193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT02299193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02299193 about?
NCT02299193 is a clinical study titled "Online CBT-I for High Blood Pressure". The purpose of this study is to compare the effect of 6-weekly, 20 minute sessions of 2 online behavioral sleep interventions (cognitive behavioral therapy or healthy sleep habits) on blood pressure, sleep, depressive symptoms and anxiety in people with insomnia and prehypertension or hypertension.
What is the current status of trial NCT02299193?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2014-08. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02299193?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Healthy Sleep Habits (BEHAVIORAL).
Who is sponsoring clinical trial NCT02299193?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02299193's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia